Regulatory News
Friday, September 2, 2016
U.S. lawmakers question Mylan's Medicaid EpiPen rebates
Sept 2 (Reuters) - Two key U.S. congressional committee
members on Friday called for an investigation into whether Mylan
NV, under fire for raising the price of its EpiPen
device, overcharged the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment